Elliptic Laboratories Financials
| ELABS Stock | NOK 9.47 0.33 3.37% |
Elliptic |
Understanding current and past Elliptic Laboratories Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Elliptic Laboratories' financial statements are interrelated, with each one affecting the others. For example, an increase in Elliptic Laboratories' assets may result in an increase in income on the income statement.
Elliptic Laboratories Stock Summary
Elliptic Laboratories competes with Polight ASA, ExpreS2ion Biotech, Kongsberg Automotive, and Everfuel. Elliptic Laboratories AS provides software-based artificial intelligence virtual smart sensors in Norway, China, South Korea, the United States, and Japan. The company was founded in 2006 and is based in Oslo, Norway. ELLIPTIC LABORATOR is traded on Oslo Stock Exchange in Norway.| Instrument | Norway Stock View All |
| Exchange | Oslo Stock Exchange |
| ISIN | NO0010722283 |
| Business Address | Akersgata 32, Oslo, |
| Sector | Technology |
| Industry | Software—Application |
| Benchmark | Dow Jones Industrial |
| Website | www.ellipticlabs.com |
| Phone | 47 40 28 40 28 |
| Currency | NOK - Kroner |
You should never invest in Elliptic Laboratories without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Elliptic Stock, because this is throwing your money away. Analyzing the key information contained in Elliptic Laboratories' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Elliptic Laboratories Key Financial Ratios
Elliptic Laboratories' financial ratios allow both analysts and investors to convert raw data from Elliptic Laboratories' financial statements into concise, actionable information that can be used to evaluate the performance of Elliptic Laboratories over time and compare it to other companies across industries.| Return On Equity | -0.0289 | |||
| Return On Asset | -0.0328 | |||
| Target Price | 32.0 | |||
| Number Of Employees | 69 | |||
| Beta | 0.62 |
Elliptic Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elliptic Laboratories's current stock value. Our valuation model uses many indicators to compare Elliptic Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elliptic Laboratories competition to find correlations between indicators driving Elliptic Laboratories's intrinsic value. More Info.Elliptic Laboratories AS is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Elliptic Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Elliptic Laboratories' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Elliptic Laboratories Systematic Risk
Elliptic Laboratories' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Elliptic Laboratories volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Elliptic Laboratories correlated with the market. If Beta is less than 0 Elliptic Laboratories generally moves in the opposite direction as compared to the market. If Elliptic Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Elliptic Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Elliptic Laboratories is generally in the same direction as the market. If Beta > 1 Elliptic Laboratories moves generally in the same direction as, but more than the movement of the benchmark.
Elliptic Laboratories November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Elliptic Laboratories help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Elliptic Laboratories AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Elliptic Laboratories AS based on widely used predictive technical indicators. In general, we focus on analyzing Elliptic Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Elliptic Laboratories's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 23.83 | |||
| Value At Risk | (5.01) | |||
| Potential Upside | 4.69 |
Other Information on Investing in Elliptic Stock
Elliptic Laboratories financial ratios help investors to determine whether Elliptic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elliptic with respect to the benefits of owning Elliptic Laboratories security.